Women Up, Men Down: The Clinical Impact of Replacing the Framingham Risk Score with the Reynolds Risk Score in the United States Population

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Tattersall, Matthew C ^a   Gangnon, Ronald E ^a   Karmali, Kunal N ^a   Keevil, Jon G ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FRAMINGHAM RISK SCORE; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; REYNOLDS RISK SCORE; SEX DIFFERENCE; UNITED STATES;

AGED; CARDIOLOGY; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; NUTRITION SURVEYS; RISK; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; UNITED STATES;

EID: 84866314872     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044347     Document Type: Article

References (33)

1. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285: 2486-2497.
2. Sheridan SL, Crespo E, (2008) Does the routine use of global coronary heart disease risk scores translate into clinical benefits or harms? A systematic review of the literature. BMC Health Serv Res 8: 60.
3. Ridker PM, Buring JE, Rifai N, Cook NR, (2007) Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA 297: 611-619.
4. Ridker PM, Paynter NP, Rifai N, Gaziano JM, Cook NR (2008) C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation 118: 2243-2251, 2244p following 2251.
5. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, et al. (2003) Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24: 987-1003.
6. Woodward M, Brindle P, Tunstall-Pedoe H, (2007) Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC). Heart 93: 172-176.
7. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, et al. (2008) General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117: 743-753.
8. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, et al. (2008) Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ 336: 1475-1482.
9. Genest J, McPherson R, Frohlich J, Anderson T, Campbell N, et al. (2009) 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult- 2009 recommendations. Can J Cardiol 25: 567-579.
10. Redberg RF, Benjamin EJ, Bittner V, Braun LT, Goff DC Jr, et al. (2009) ACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease) developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association: endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research. J Am Coll Cardiol 54: 1364-1405.
11. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, et al. (2010) 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the american college of cardiology foundation/american heart association task force on practice guidelines. Circulation 122: e584-636.
12. (2005) National Health and Nutrition Examination Survey (NHANES) analytic and reporting guidelines. Hyattsville, Maryland: National Center for Health Statistics, Centers for Disease Control and Prevention.
13. Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, et al. (2002) 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 11: 1-190.
14. Flegal KM, Carroll MD, Ogden CL, Curtin LR, (2010) Prevalence and trends in obesity among US adults, 1999-2008. JAMA 303: 235-241.
15. Ford ES, Giles WH, Mokdad AH, (2004) Increasing prevalence of the metabolic syndrome among u.s. Adults. Diabetes Care 27: 2444-2449.
16. Michos ED, Blumenthal RS, (2009) Prevalence of low low-density lipoprotein cholesterol with elevated high sensitivity C-reactive protein in the U.S.: implications of the JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin) study. J Am Coll Cardiol 53: 931-935.
17. Imperatore G, Cadwell BL, Geiss L, Saadinne JB, Williams DE, et al. (2004) Thirty-year trends in cardiovascular risk factor levels among US adults with diabetes: National Health and Nutrition Examination Surveys, 1971-2000. Am J Epidemiol 160: 531-539.
18. Sundquist J, Winkleby MA, Pudaric S, (2001) Cardiovascular disease risk factors among older black, Mexican-American, and white women and men: an analysis of NHANES III, 1988-1994. Third National Health and Nutrition Examination Survey. J Am Geriatr Soc 49: 109-116.
19. Ford ES, Giles WH, Mokdad AH, (2004) The distribution of 10-Year risk for coronary heart disease among US adults: findings from the National Health and Nutrition Examination Survey III. J Am Coll Cardiol 43: 1791-1796.
20. Friedewald WT, Levy RI, Fredrickson DS, (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502.
21. Pasternak RC, Abrams J, Greenland P, Smaha LA, Wilson PW, et al. (2003) 34th Bethesda Conference: Task force #1-Identification of coronary heart disease risk: is there a detection gap? J Am Coll Cardiol 41: 1863-1874.
22. Greenland P, Smith SC Jr, Grundy SM, (2001) Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests. Circulation 104: 1863-1867.
23. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, et al. (2004) Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol 44: 720-732.
24. D'Agostino RB Sr, Grundy S, Sullivan LM, Wilson P, (2001) Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 286: 180-187.
25. Voight BF, Peloso GM, Orho-Melander M, Frikke-Schmidt R, Barbalic M, et al. (2012) Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet.
26. Wensley F, Gao P, Burgess S, Kaptoge S, Di Angelantonio E, et al. (2011) Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. BMJ 342: d548.
27. Cook NR, Paynter NP, Eaton CB, Manson JE, Martin LW, et al. (2012) Comparison of the Framingham and Reynolds Risk scores for global cardiovascular risk prediction in the multiethnic Women's Health Initiative. Circulation 125: 1748-1756, S1741-1711.
28. Lloyd-Jones DM, Leip EP, Larson MG, D'Agostino RB, Beiser A, et al. (2006) Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation 113: 791-798.
29. Lloyd-Jones DM, Wilson PW, Larson MG, Beiser A, Leip EP, et al. (2004) Framingham risk score and prediction of lifetime risk for coronary heart disease. Am J Cardiol 94: 20-24.
30. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, et al. (2012) Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 125: e2-e220.
31. Amarenco P, Labreuche J, (2009) Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol 8: 453-463.
32. Amarenco P, Labreuche J, Lavallee P, Touboul PJ, (2004) Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke 35: 2902-2909.
33. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27: 157-172; discussion 207-112.